TROPIKANA

TROP-2 CAR-engineered IL15-transduced cord blood-derived NK cells · MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TROPIKANA, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA) [Phase 1]

See pricing